Detalhe da pesquisa
1.
Epigenetic therapy inhibits metastases by disrupting premetastatic niches.
Nature
; 579(7798): 284-290, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32103175
2.
A Multidisciplinary Toxicity Team for Cancer Immunotherapy-Related Adverse Events.
J Natl Compr Canc Netw
; 17(6): 712-720, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31200355
3.
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung Cancer.
Clin Cancer Res
; 29(4): 705-710, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794455
4.
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology.
J Immunother Cancer
; 11(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001909
5.
Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers.
J Immunother Cancer
; 9(8)2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34380662
6.
Chronic immune checkpoint inhibitor pneumonitis.
J Immunother Cancer
; 8(1)2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32554618
7.
Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1.
J Immunother Cancer
; 7(1): 63, 2019 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30841906
8.
Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1.
J Immunother Cancer
; 7(1): 40, 2019 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30744692